Postoperative synthetic human atrial natriuretic peptide infusion and oral spironolactone administration for a patient with giant atria and low plasma level of atrial natriuretic peptide.
Hayashi
Yoshitaka
Y
Division of Cardiovascular Surgery, Osaka Minami National Hospital, Osaka, Japan. yhayashi@jun.ncvc.go.jp
Ohtani
Masakatsu
M
Hiraishi
Taizo
T
Kobayashi
Yasuhiko
Y
D000284:Administration, Oral; D009320:Atrial Natriuretic Factor / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D002315:Cardiopulmonary Bypass; D005260:Female; D006333:Heart Failure / Q000209:etiology; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D008946:Mitral Valve Stenosis / Q000150:complications / Q000601:surgery; D011182:Postoperative Care; D013148:Spironolactone / Q000008:administration & dosage / Q000627:therapeutic use*; D014262:Tricuspid Valve Insufficiency / Q000150:complications / Q000601:surgery
D013148:Spironolactone; D009320:Atrial Natriuretic Factor